Showing 1 - 10 of 10
Persistent link: https://www.econbiz.de/10001541401
Persistent link: https://www.econbiz.de/10003751546
Persistent link: https://www.econbiz.de/10011895565
We study spillover effects of the largest ever increase in Medicaid primary care reimbursement rates on behavioral health and healthcare outcomes; mental illness, substance use disorders, and tobacco product use. Much of the variation in Medicaid reimbursement rates we leverage is attributable...
Persistent link: https://www.econbiz.de/10012452916
We study spillover effects from the largest increase in Medicaid reimbursement rates in the history of the program for primary care services to behavioral health and healthcare outcomes; mental illness, substance use disorders, and tobacco product use. Much of the variation in Medicaid...
Persistent link: https://www.econbiz.de/10012914725
"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. Public subsidization of technology assessments in general, and Comparative Effectiveness Research (CER) in particular, has received...
Persistent link: https://www.econbiz.de/10003925198
Persistent link: https://www.econbiz.de/10009303017
Public technology assessments in general and Comparative Effectiveness Research (CER) in particular have been justified by offsetting benefits of improving patient health and reducing health care spending. However, little conceptual and empirical understanding exists concerning the quantitative...
Persistent link: https://www.econbiz.de/10012463017
Public subsidization of technology assessments in general, and Comparative Effectiveness Research (CER) in particular, has received considerable attention as a tool to simultaneously improve patient health and lower the cost of health care. However, little conceptual and empirical understanding...
Persistent link: https://www.econbiz.de/10013092707
Public technology assessments in general and Comparative Effectiveness Research (CER) in particular have been justified by offsetting benefits of improving patient health and reducing health care spending. However, little conceptual and empirical understanding exists concerning the quantitative...
Persistent link: https://www.econbiz.de/10013149296